Miriam E. Tucker

News

Zostavax Effective Against Herpes Zoster in 50- to 59-Year-Olds

Author:: Miriam E. Tucker

Publish date: March 21, 2011

Major Finding: There were 30 confirmed cases of herpes zoster among the 11,211 Zostavax recipients, compared with 99 among the 11,228 on placebo, ...

News

Zostavax Effective Against Herpes Zoster in 50- to 59-Year-Olds

Author:: Miriam E. Tucker

Publish date: March 21, 2011

Major Finding: There were 30 confirmed cases of herpes zoster among the 11,211 Zostavax recipients, compared with 99 among the 11,228 on placebo, ...

News

Thrice-Weekly Insulin Degludec Comparable to Daily Glargine

Author:: Miriam E. Tucker

Publish date: March 9, 2011

Major Finding: Reductions in HbA1c from baseline were between 1.3% and 1.5% (to 7.2%-7.5%) and did not differ significantly between groups taking ...

News

Thrice-Weekly Insulin Degludec Comparable to Daily Glargine

Author:: Miriam E. Tucker

Publish date: March 9, 2011

Major Finding: Reductions in HbA1c from baseline were between 1.3% and 1.5% (to 7.2%-7.5%) and did not differ significantly between groups taking ...

News

Thrice-Weekly Insulin Degludec Comparable to Daily Glargine

Author:: Miriam E. Tucker

Publish date: March 9, 2011

Major Finding: Reductions in HbA1c from baseline were between 1.3% and 1.5% (to 7.2%-7.5%) and did not differ significantly between groups taking ...

News

Olmesartan Delays Microalbuminuria Onset in Type 2 Diabetes

Author:: Miriam E. Tucker

Publish date: March 9, 2011

Major Finding: The median time to onset of microalbuminuria – the primary study end point – was 576 days in the placebo group and 722 ...

News

Olmesartan Delays Microalbuminuria Onset in Type 2 Diabetes

Author:: Miriam E. Tucker

Publish date: March 9, 2011

Major Finding: The median time to onset of microalbuminuria – the primary study end point – was 576 days in the placebo group and 722 ...

News

Olmesartan Delays Microalbuminuria Onset in Type 2 Diabetes

Author:: Miriam E. Tucker

Publish date: March 9, 2011

Major Finding: The median time to onset of microalbuminuria – the primary study end point – was 576 days in the placebo group and 722 ...

News

Acute Hepatitis B Incidence Double in People With Diabetes

Author:: Miriam E. Tucker

Publish date: March 3, 2011

Major Finding: The estimated annual incidence of acute hepatitis B per 100,000 adults aged 23 years and older was 1.4 for those with diabetes vers...

News

Acute Hepatitis B Incidence Double in People With Diabetes

Author:: Miriam E. Tucker

Publish date: March 3, 2011

Major Finding: The estimated annual incidence of acute hepatitis B per 100,000 adults aged 23 years and older was 1.4 for those with diabetes vers...

News

Acute Hepatitis B Incidence Double in People With Diabetes

Author:: Miriam E. Tucker

Publish date: March 3, 2011

Major Finding: The estimated annual incidence of acute hepatitis B per 100,000 adults aged 23 years and older was 1.4 for those with diabetes vers...

News

ACR/EULAR Criteria Define RA Remission

Author:: Miriam E. Tucker

Publish date: March 3, 2011

News

ACR/EULAR Criteria Define RA Remission

Author:: Miriam E. Tucker

Publish date: March 3, 2011

News

Small Increase in Febrile Seizures With Fluzone Plus Prevnar 13

Author:: Miriam E. Tucker

Publish date: March 1, 2011

Major Finding: Preliminary data suggest one excess febrile seizure for every 1,640 vaccinees aged 12–23 months who receive Fluzone and Pre...

News

Pertussis Vaccine Urged for All Health Workers

Author:: Miriam E. Tucker

Publish date: March 1, 2011